Scott, Rhona

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study

Pratley, R. E., Nauck, M. A., Barnett, A. H., Feinglos, M. N., Ovalle, F., Harman-Boehm, I., Ye, J., Scott, R., Johnson, S., Stewart, M., et al. (2014) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 326

Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist

Young, M. A., Wald, J. A., Matthews, J. E., Scott, R., Hodge, R. J., Zhi, H., & Reinhardt, R. R. (2014) · Postgraduate Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 41

Effects of Multiple Doses of Albiglutide on the Pharmacokinetics, Pharmacodynamics, and Safety of Digoxin, Warfarin, or a Low-Dose Oral Contraceptive

Bush, M., Scott, R., Watanalumlerd, P., Zhi, H., & Lewis, E. (2012) · Postgraduate Medicine

Pharmacogenetics and Drug MetabolismDiabetes Treatment and Management

Cited by 30